rss
J Neurol Neurosurg Psychiatry 2009;80:976-978 doi:10.1136/jnnp.2007.138586
  • Research paper

Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial

  1. C E Clarke1,2,
  2. A Furmston3,
  3. E Morgan4,
  4. S Patel3,4,
  5. C Sackley4,
  6. M Walker5,
  7. S Bryan6,
  8. K Wheatley3
  1. 1
    Department of Neurology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
  2. 2
    School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
  3. 3
    University of Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
  4. 4
    Primary Care and General Practice, University of Birmingham, Birmingham, UK
  5. 5
    Division of Rehabilitation and Ageing, University of Nottingham, Nottingham, UK
  6. 6
    Health Service Management Centre, University of Birmingham, Birmingham, UK
  1. Correspondence to Professor C E Clarke, Department of Neurology, City Hospital, Dudley Road, Birmingham B18 7QH, UK; c.e.clarke{at}bham.ac.uk
  • Received 1 November 2007
  • Revised 21 February 2008
  • Accepted 26 February 2008

Abstract

Objective: To perform a pilot trial of occupational therapy (OT) to optimise functional independence in Parkinson disease (PD) to assess accrual/withdrawal rates, acceptability, outcome measures, and inform sample-size calculation.

Method: Non-demented patients with idiopathic PD and difficulties with activities of daily living (ADL) were recruited provided they had not received OT in the last 2 years and/or physiotherapy in the last year. Patients were randomised to immediate OT or OT after completion of the trial. Patients randomised to OT were assessed at home by an experienced therapist and then received six home treatment sessions over 2 months. Interventions were targeted at functional independence and mobility goals. Outcome measures were: Nottingham Extended Activity of Daily Living Scale, Rivermead Mobility Index, Unified Parkinson’s Disease Rating Scale ADL scale, Parkinson’s Disease Questionnaire 39, EuroQol-EQ-5D, Hospital Anxiety and Depression Scale, and health economics analysis.

Results: 39 patients (25 male; mean age 73 years) were recruited from four centres over 16 months. The mean difference in NEADL at 8 months was 3.5 (95% CI −3.2 to 10.2). The mean difference in PDQ-39 Summary Score was 3.8 (95% CI −4.94 to 12.6). There were strong correlations between the PDQ-39 and other outcomes. The intervention was acceptable to patients, with a low withdrawal rate and good questionnaire completion.

Conclusion: Randomisation to a trial of OT in PD is feasible. NEADL and PDQ-39 are relevant outcomes and provided data to inform sample size for an adequately powered randomised trial for which there is pressing need.

Footnotes

  • Funding Parkinson’s Disease Society, Health Foundation and Department of Health NCCRDC.

  • Competing interests None.

  • Ethics approval Ethics approval was provided by Sandwell and West Birmingham Local Research Ethics Committee.

  • Patient consent Obtained.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jnnp.2007.138586v1
    2. 80/9/976 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs